Ulteriori informazioni
Designed for the general psychiatrist and mental health specialist, Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice offers the most up-to-date information for referring and comanaging patients who are candidates for transcranial magnetic stimulation (TMS). This information is difficult to find because the majority of psychiatric residency programs do not offer any curriculum on TMS therapy and continuing education conferences are limited. TMS is a specific form of neuromodulation cleared by the U.S. Food and Drug Administration in 2008 for the treatment of adult patients with major depression who have not responded to antidepressant medications. Since then, TMS has expanded rapidly into the clinical arena and now constitutes an established treatment modality with broad insurance coverage, expanded patient access, and potential utilization for other neuropsychiatric disorders.
Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice is a practical reference for the management of depressed patients who are candidates for TMS and an invaluable resource for clinicians seeking knowledge about the most important development in the treatment of depression in the last decade.
Info autore
Richard A. Bermudes, M.D., is the Chief Medical Officer at TMS Health Solutions and is an Assistant Clinical Professor-Volunteer in the Department of Psychiatry at the University of California, San Francisco in San Francisco, California.
Karl I. Lanocha, M.D., is the Director of Education at TMS Health Solutions in San Francisco, California.
Philip G. Janicak, M.D., is an Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Northwestern University, Feinberg School of Medicine and Director of the Transcranial Magnetic Stimulation Center at Edward/Elmhurst Healthcare in Naperville, Illinois.
Riassunto
Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice is a practical reference for the management of depressed patients who are candidates for TMS and an invaluable resource for clinicians seeking knowledge about the most important development in the treatment of depression in the last decade.
